Campbell & CO Investment Adviser LLC

Position in ADMA — Adma Biologics, Inc.

CIK 1353570 BALTIMORE, MD

Position in ADMA

as of Jun 30, 2026 · filed Aug 3, 2026 Compact

Position Value

$1,875,214

+$636,628 QoQ

Shares Held

224,040

+63.0% QoQ

Ownership

0.100%

of shares outstanding

% of Portfolio

0.10%

of 13F equity value

Holder Rank

#83

of 323 holders

Holding Since

Sep 2023

10 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Campbell & CO Investment Adviser LLC holds $72,173,828 across 47 Biotechnology names. ADMA ranks #13 (2.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	9,899	$6,172,422
2	CRSP	CRISPR Therapeutics AG	107,529	$5,864,631
3	CYTK	Cytokinetics Inc	65,978	$5,620,665
4	INSM	INSMED Inc	43,856	$4,675,926
5	IONS	Ionis Pharmaceuticals Inc	49,632	$3,935,321
6	HALO	Halozyme Therapeutics, Inc.	44,702	$3,498,825
7	ALNY	Alnylam Pharmaceuticals, Inc.	11,183	$3,366,418
8	RPRX	Royalty Pharma plc	52,688	$2,954,216

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,875,214	224,040	+63.0%	Shares	Sole	2026-08-03
2026-03-31	$1,238,586	137,468	+113.0%	Shares	Sole	2026-05-15
2025-09-30	$946,083	64,535	-28.2%	Shares	Sole	2025-10-28
2025-03-31	$1,782,504	89,844	+100.2%	Shares	Sole	2025-05-14
2024-12-31	$769,812	44,887	-23.7%	Shares	Sole	2025-02-10
2024-09-30	$1,175,611	58,810	-56.3%	Shares	Sole	2024-11-12
2024-06-30	$1,505,476	134,658	-42.0%	Shares	Sole	2024-08-13
2024-03-31	$1,531,985	232,119	+61.8%	Shares	Sole	2024-05-10
2023-12-31	$648,276	143,424	+19.2%	Shares	Sole	2024-02-13
2023-09-30	$430,663	120,297	—	Shares	Sole	2023-11-08
No filing history on record for this holder in this stock.